company background image
524689 logo

Parenteral Drugs (India) BSE:524689 Stock Report

Last Price

₹3.39

Market Cap

₹101.1m

7D

0%

1Y

-33.7%

Updated

17 Nov, 2023

Data

Company Financials

Parenteral Drugs (India) Limited

BSE:524689 Stock Report

Market Cap: ₹101.1m

524689 Stock Overview

Parenteral Drugs (India) Limited operates as a healthcare company in India.

524689 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Parenteral Drugs (India) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Parenteral Drugs (India)
Historical stock prices
Current Share Price₹3.39
52 Week High₹5.11
52 Week Low₹3.08
Beta0
11 Month Change0%
3 Month Change4.63%
1 Year Change-33.66%
33 Year Changen/a
5 Year Change-63.90%
Change since IPO5.73%

Recent News & Updates

Recent updates

Shareholder Returns

524689IN PharmaceuticalsIN Market
7D0%-1.5%-0.8%
1Y-33.7%50.3%34.7%

Return vs Industry: 524689 underperformed the Indian Pharmaceuticals industry which returned 30.4% over the past year.

Return vs Market: 524689 underperformed the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 524689's price volatile compared to industry and market?
524689 volatility
524689 Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524689 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 524689's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1983n/an/awww.pdindia.com

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon.

Parenteral Drugs (India) Limited Fundamentals Summary

How do Parenteral Drugs (India)'s earnings and revenue compare to its market cap?
524689 fundamental statistics
Market cap₹101.08m
Earnings (TTM)-₹763.62m
Revenue (TTM)₹84.96m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524689 income statement (TTM)
Revenue₹84.96m
Cost of Revenue₹54.66m
Gross Profit₹30.31m
Other Expenses₹793.93m
Earnings-₹763.62m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 524689 perform over the long term?

See historical performance and comparison